Financial Position - As of December 31, 2024, the company had cash and cash in escrow of 152,021andaworkingcapitaldeficitof128,968[325] - As of December 31, 2024, the company had cash at bank of 152,021andnocashinescrow[332]−Theprincipalamountdueunderapromissorynotefromthesponsorwas0 as of December 31, 2024[326] - The company has a promissory note with a principal amount of 300,000,whichisnon−interest−bearingandpayableupontheconsummationoftheinitialbusinesscombination[333]BusinessCombination−ThecompanyenteredintoabusinesscombinationagreementwithMaiusPharmaceuticalCo.,Ltd.onOctober22,2024[320]−ThecompanyhasadeadlinetocompletetheinitialbusinesscombinationbyApril23,2025,withthepossibilityofextendingitupto27months[317]−ThecompanyhasextendedthedeadlineforcompletingtheinitialbusinesscombinationtoApril23,2025,withthepossibilityoffurtherextensions[327]−Thecompanyisrequiredtosecureatleast10,000,000 in private equity investments from third-party investors as part of the business combination[324] - The first monthly extension fee of 207,000wasdepositedintotheTrustAccounttoextendthedeadlineforthebusinesscombination[317]−Thecompanymayfacesignificantdilutionofequityinterestsifadditionalsharesareissuedinconnectionwiththebusinesscombination[313]−Theunderwritersareentitledtoacashunderwritingdiscountof2.51,725,000, upon the closing of the initial business combination[339] Financial Performance - The company reported a net income of 2,265,806fortheyearendedDecember31,2024[325]−FortheyearendedDecember31,2024,thecompanyreportedanetincomeof2,265,806, primarily from dividend income of 3,000,071[337]−Thecompanyincurredcashusedinoperatingactivitiesof686,691 for the year ended December 31, 2024[331] - The company has not generated any revenues to date and has focused on preparing for its initial public offering[312] Initial Public Offering - The company completed its initial public offering on February 23, 2024, raising gross proceeds of 69,000,000fromthesaleof6,900,000unitsat10.00 per unit[329] - Following the IPO, a total of $69,345,000 was deposited in the trust account, intended for the initial business combination[330] Going Concern - The company may face substantial doubt about its ability to continue as a going concern if it fails to complete the initial business combination within the prescribed time[328] Accounting Estimates - The company has not identified any critical accounting estimates that could materially affect its financial statements[340]